Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Stingray Therapeutics
Scientific Title
Phase 1, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of SR-8541A (ENPP1 Inhibitor) Administered Orally as Monotherapy in Subjects With Advanced/Metastatic Solid Tumors